SCHEMBL745064

SCHEMBL745064

CCOC(=O)CC[As](C)Cc1coc2cc(Oc3nc4ncccc4s3)ccc12

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL750604 0.90 LTA4H (0.60) LTA4H
SCHEMBL744344 0.84 LTA4H (0.57) LTA4H
SCHEMBL3748603 0.80 LTA4H (0.71) LTA4H
SCHEMBL743827 0.80 LTA4H (0.57) LTA4H
SCHEMBL3746639 0.78 LTA4H (0.69) LTA4H
SCHEMBL3746807 0.78 LTA4H (0.82) LTA4H
SCHEMBL3746373 0.77 LTA4H (0.69) LTA4H
SCHEMBL744597 0.77 LTA4H (0.71) LTA4H
SCHEMBL3477170 0.77 LTA4H (0.71) LTA4H
SCHEMBL744912 0.76 LTA4H (0.66) LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430019-A1 COMPOUNDS WITH TWO FUSED BICYCLIC HETEROARYL MOIETIES AS MODULATORS OF LEUKOTRIENE A4 HYDROLASE Janssen Pharmaceutica, N.V. (BE) 2012-03-21 EP claimed
WO-2010132599-A1 COMPOUNDS WITH TWO FUSED BICYCLIC HETEROARYL MOIETIES AS MODULATORS OF LEUKOTRIENE A4 HYDROLASE JANSSEN PHARMACEUTICA NV (BE) 2010-11-18 WO claimed